NEW YORK, Sept. 27 - Sequitur and Discovery Genomics have partnered to screen antisense compounds and study gene function in zebra fish, according to both companies. 

The multiyear agreement calls for Sequitur to use its antisense compounds and high throughput gene expression analysis. Discovery Genomics will bring to the table its functional genomics experience with the zebra fish model. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.